Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katayoun Alikhani

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendationsDouglas L Arnold, David Li, Marika Hohol, et al.
Current Stem Cell Research & Therapy|October 16, 2012
Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label studyMandana Mohyeddin Bonab, Mohammad Ali Sahraian, Aida Aghsaie, et al.
Plos One|April 14, 2015
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort studySimon Zhornitsky, Jamie Greenfield, Marcus W Koch, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 5, 2024
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsChristopher Hahn, Adrian Budhram, Katayoun Alikhani, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendationsDouglas L Arnold, David Li, Marika Hohol, et al.
Current Stem Cell Research & Therapy|October 16, 2012
Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label studyMandana Mohyeddin Bonab, Mohammad Ali Sahraian, Aida Aghsaie, et al.
Plos One|April 14, 2015
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort studySimon Zhornitsky, Jamie Greenfield, Marcus W Koch, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 5, 2024
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsChristopher Hahn, Adrian Budhram, Katayoun Alikhani, et al.
Pageof 2